1-6 of 6
rapamycin
Close
Sort by
Journal Articles

Is there a role for immunosuppression in antiphospholipid syndrome?

Ecem Sevim, Rohan Willis, Doruk Erkan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 426–432.
https://doi.org/10.1182/hematology.2019000073
Published: 2019
Journal Articles

Management of Myelofibrosis

Alessandro M. Vannucchi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 222–230.
https://doi.org/10.1182/asheducation-2011.1.222
Published: 2011
Journal Articles

Assessing New Therapies and Their Overall Impact in Myelofibrosis

Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 115–121.
https://doi.org/10.1182/asheducation-2010.1.115
Published: 2010
Journal Articles

Signal Transduction Inhibitor Therapy for Lymphoma

Thomas E. Witzig, Mamta Gupta
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 265–270.
https://doi.org/10.1182/asheducation-2010.1.265
Published: 2010
Journal Articles

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

Junia V. Melo, Charles Chuah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 427–435.
https://doi.org/10.1182/asheducation-2008.1.427
Published: 2008
Journal Articles

Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma

Julie M. Vose, Brian C.-H. Chiu, Bruce D. Cheson, Janet Dancey, John Wright
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2002) 2002 (1): 241–262.
https://doi.org/10.1182/asheducation-2002.1.241
Published: 2002